Illumina is trading at $247.20, 4.75% up in pre-market on November 2, rebounding after its October 30 close of $235.99; no new company-specific catalyst was identified.

  • The gain comes amid a modest rebound in U.S. futures.
  • The steep post-earnings decline reflected investor concerns about revenue growth and China, despite the raised full-year outlook.
  • On October 29, Illumina raised 2026 revenue guidance to $4.64–$4.66 billion and adjusted EPS guidance to $5.40–$5.45.